Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective (Q41243687)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective |
scientific article |
Statements
1 reference
Characterisation and clinical management of CPT-11 (irinotecan)-induced adverse events: the European perspective (English)
1 reference
H Bleiberg
1 reference
E Cvitkovic
1 reference
1 January 1996
1 reference
1 reference
32A Suppl 3
1 reference
S18-23
1 reference
Identifiers
1 reference
1 reference